Associate Professor, Pathology, University of Pittsburgh School of Medicine
Pathology
Dr. Marina N. Nikiforova, MD
|
|
Give Review
Marina N. Nikiforova, MD works in the field of Pathology. She graduated from University Hospital - University of Cincinnati College of Medicine. Marina Nikiforova has written publications. She has 100 publications published with PubMed. The lastest publication is: 'Prevalence of minisatellite and microsatellite instability in radiation-induced post-Chernobyl pediatric thyroid carcinomas.' Marina Nikiforova is registered with Medicare.
Publications
- Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors.
- Targeted Next-Generation Sequencing Analysis of a Pendred Syndrome-Associated Thyroid Carcinoma.
- A Multiplexed Amplicon Approach for Detecting Gene Fusions by Next-Generation Sequencing.
- Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.
- Histopathologic and Clinical Characterization of Thyroid Tumors Carrying the BRAF(K601E) Mutation.
- Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of...
- Molecular Characterization of Apocrine Salivary Duct Carcinoma.
- Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics.
- The Cancer Genomics Resource List 2014.
- Epithelioid cell histiocytoma of the skin with clonal ALK gene rearrangement resulting in VCL-ALK and SQSTM1-ALK gene fusions.
- Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing...
- Predicting the likelihood of an isocitrate dehydrogenase 1 or 2 mutation in diagnoses of infiltrative glioma.
- PAX8/PPARγ Rearrangement in Thyroid Nodules Predicts Follicular-Pattern Carcinomas, in Particular the Encapsulated Follicular Variant of Papillary Carcinoma.
- Erlotinib, erlotinib-sulindac vs. placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancer.
- Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a thre...
- Correlation of Cytomorphology and Molecular Findings in EGFR+, KRAS+, and ALK+ Lung Carcinomas.
- Serrated lesions of the appendix frequently harbor KRAS mutations and not BRAF mutations indicating a distinctly different serrated neoplastic pathway in the appendix.
- SeqReporter: Automating Next-Generation Sequencing Result Interpretation and Reporting Workflow in a Clinical Laboratory.
- ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer.
- Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts.
- Targeted Next-Generation Sequencing Panel (ThyroSeq) for Detection of Mutations in Thyroid Cancer.
- Human Papillomavirus-Associated Adenocarcinoma of the Base of Tongue: Potentially Actionable Genetic Changes.
- 1p/19q testing has no significance in the workup of glioblastomas.
- Lynch syndrome-associated colorectal carcinoma: frequent involvement of the left colon and rectum and late-onset presentation supports a universal screening approach.
- "Colloid-Rich" follicular neoplasm/suspicious for follicular neoplasm thyroid fine-needle aspiration specimens: Cytologic, histologic, and molecular basis for consider...
- Clinicopathologic Features of Synchronous Colorectal Carcinoma: A Distinct Subset Arising From Multiple Sessile Serrated Adenomas and Associated With High Levels of Mi...
- Pulmonary Langerhans cell histiocytosis: profiling of multifocal tumors using next-generation sequencing identifies concordant occurrence of BRAF V600E mutations.
- RAS Mutations in Thyroid FNA Specimens Are Highly Predictive of Predominantly Low-Risk Follicular-Pattern Cancers.
- Signet Ring Cell Colorectal Carcinoma: A Distinct Subset of Mucin-poor Microsatellite-stable Signet Ring Cell Carcinoma Associated With Dismal Prognosis.
- New Strategies in Diagnosing Cancer in Thyroid Nodules: Impact of Molecular Markers.
- A Novel COLD-PCR/FMCA Assay Enhances the Detection of Low-abundance IDH1 Mutations in Gliomas.
- Comprehensive microRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.
- BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer.
- MicroRNA Expression Array Identifies Novel Diagnostic Markers for Conventional and Oncocytic Follicular Thyroid Carcinomas.
- BRAF mutation detection in indeterminate thyroid cytology specimens: Underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma.
- Prospective testing of mucoepidermoid carcinoma for the MAML2 translocation: Clinical Implications.
- Optic pathway glioma as part of a constitutional mismatch-repair deficiency syndrome in a patient meeting the criteria for neurofibromatosis type 1.
- Cytomorphological and molecular genetic findings in pediatric thyroid fine-needle aspiration.
- Cost impact of molecular testing for indeterminate thyroid nodule fine-needle aspiration biopsies.
- Validation of KRAS Testing for Anti-EGFR Therapeutic Decisions for Patients With Metastatic Colorectal Carcinoma.
- The importance of 10q status in an outcomes-based comparison between 1p/19q fluorescence in situ hybridization and polymerase chain reaction-based microsatellite loss ...
- Impact of Mutational Testing on the Diagnosis and Management of Patients with Cytologically Indeterminate Thyroid Nodules: A Prospective Analysis of 1056 FNA Samples.
- Molecular genetics and diagnosis of thyroid cancer.
- Grade II oligodendroglioma localized to the corpus callosum.
- MicroRNA Signature Distinguishes the Degree of Aggressiveness of Papillary Thyroid Carcinoma.
- Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancer.
- Molecular diagnostics of gliomas.
- MicroRNA dysregulation in human thyroid cells following exposure to ionizing radiation.
- Challenging cases encountered in colorectal cancer screening for Lynch syndrome reveal novel findings: nucleolar MSH6 staining and impact of prior chemoradiation therapy.
- miRNA expression profiling of lung adenocarcinomas: correlation with mutational status.
- EGFR fluorescence in situ hybridization-positive lung adenocarcinoma: incidence of coexisting KRAS and BRAF mutations.
- A reappraisal of the MECT1/MAML2 translocation in salivary mucoepidermoid carcinomas.
- The prognostic value of Ki-67, p53, epidermal growth factor receptor, 1p36, 9p21, 10q23, and 17p13 in skull base chordomas.
- Detection of IDH1 and IDH2 mutations by fluorescence melting curve analysis as a diagnostic tool for brain biopsies.
- Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significanc...
- A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases.
- Molecular diagnostics and predictors in thyroid cancer.
- Diagnostic use of IDH1/2 mutation analysis in routine clinical testing of formalin-fixed, paraffin-embedded glioma tissues.
- Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation.
- The role of KRAS mutation testing in the management of patients with metastatic colorectal cancer.
- Mammalian mastermind like 2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma.
- Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.
- Micropapillary lung adenocarcinoma: EGFR, K-ras, and BRAF mutational profile.
- Gene position within chromosome territories correlates with their involvement in distinct rearrangement types in thyroid cancer cells.
- MicroRNA expression profiles in thyroid tumors.
- Tumor-to-tumor metastases to follicular variant of papillary thyroid carcinoma: histologic, immunohistochemical, and molecular studies of two unusual cases.
- Loss of heterozygosity of selected tumor suppressor genes in parathyroid carcinoma.
- Loss of heterozygosity predicts poor survival after resection of pancreatic adenocarcinoma.
- Two sites of head and neck squamous cell carcinoma: utility of loss of heterozygosity.
- MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility.
- Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity.
- Detection of SYT-SSX rearrangements in synovial sarcomas by real-time one-step RT-PCR.
- Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer.
- Regulation of p27Kip1 protein levels contributes to mitogenic effects of the RET/PTC kinase in thyroid carcinoma cells.
- BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.
- Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations.
- RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.
- High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcin...
- PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses.
- Prevalence of RET/PTC rearrangements in Hashimoto's thyroiditis and papillary thyroid carcinomas.
- BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi.
- MicroRNA profile of poorly differentiated thyroid carcinomas: new diagnostic and prognostic insights.
- PIK3CA, HRAS and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinoma.
- IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children''s Oncology Group.
- Akt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children''s Oncology Group.
- Mismatch repair deficiency is an uncommon mechanism of alkylator resistance in pediatric malignant gliomas: a report from the Children''s Oncology Group.
- Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis.
- Multicenter comparison of different real-time PCR assays for quantitative detection of Epstein-Barr virus.
- Clinical laboratory reports in molecular pathology.
- Detection of clonal IGH gene rearrangements: summary of molecular oncology surveys of the College of American Pathologists.
- Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas.
- On target cell numbers in radiation-induced H4-RET mediated papillary thyroid cancer.
- Solid variant of papillary thyroid carcinoma: incidence, clinical-pathologic characteristics, molecular analysis, and biologic behavior.
- Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident.
- Frequent loss of heterozygosity at chromosome 3p14.2-3p21 in human pancreatic islet cell tumours.
- Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells.
- Chromosomal breakpoint positions suggest a direct role for radiation in inducing illegitimate recombination between the ELE1 and RET genes in radiation-induced thyroid...
- Prevalence of minisatellite and microsatellite instability in radiation-induced post-Chernobyl pediatric thyroid carcinomas.
- [Extraction and freeze-drying of herpes virus C3-1 isolated from turkeys].
Doctors Specialties
- Pathology
Accepted Insurances
Education
-
University Hospital - University of Cincinnati College of Medicine -
Minsk Medical Institute
Hospital
-
UPMC Passavant -
UPMC Presbyterian Shadyside
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1821029604 |
| Last Name Of The Provider | NIKIFOROVA |
| First Name Of The Provider | MARINA |
| View All |
Similar Doctors
|
|
Dr. Marie C. Defrances, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey L. Fine, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charleen Chu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory J. Naus, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Grant C. Bullock, MD
This Doctor is OpenDoctor Recommended.
|